ロード中...
Cancer Subclonal Genetic Architecture as a Key to Personalized Medicine
The future of personalized oncological therapy will likely rely on evidence-based medicine to integrate all of the available evidence to delineate the most efficacious treatment option for the patient. To undertake evidence-based medicine through use of targeted therapy regimens, identification of t...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Neoplasia Press Inc.
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3884532/ https://ncbi.nlm.nih.gov/pubmed/24403863 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|